+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Erythropoietin Drugs Market Research Report by Drug Class (Biologics and Biosimilars), Product, Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 249 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 4989689
UP TO OFF until Dec 31st 2022
The Global Erythropoietin Drugs Market size was estimated at USD 7,107.38 million in 2021, USD 7,673.71 million in 2022, and is projected to grow at a CAGR 8.14% to reach USD 11,369.80 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Erythropoietin Drugs to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Drug Class, the market was studied across Biologics and Biosimilars.
  • Based on Product, the market was studied across Darbepoetin-alfa, Epoetin-alfa, and Epoetin-beta.
  • Based on Application, the market was studied across Cancer, Hematology, Neurology, and Renal Diseases.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Erythropoietin Drugs market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Erythropoietin Drugs Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Erythropoietin Drugs Market, including Amgen Inc., Biocon Limited, Celltrion, Inc., Hospira Inc., Intas Pharmaceuticals, Johnson & Johnson, LG Life Sciences Ltd., Ranbaxy Laboratories Ltd., Roche Holding AG, and Teva Pharmaceutical Industries Ltd..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Erythropoietin Drugs Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Erythropoietin Drugs Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Erythropoietin Drugs Market?
4. What is the competitive strategic window for opportunities in the Global Erythropoietin Drugs Market?
5. What are the technology trends and regulatory frameworks in the Global Erythropoietin Drugs Market?
6. What is the market share of the leading vendors in the Global Erythropoietin Drugs Market?
7. What modes and strategic moves are considered suitable for entering the Global Erythropoietin Drugs Market?
Frequently Asked Questions about the Global Erythropoietin Drugs Market

What is the estimated value of the Global Erythropoietin Drugs Market?

The Global Erythropoietin Drugs Market was estimated to be valued at $7107.38 Million in 2021.

What is the growth rate of the Global Erythropoietin Drugs Market?

The growth rate of the Global Erythropoietin Drugs Market is 8.1%, with an estimated value of $11369.8 Million by 2027.

What is the forecasted size of the Global Erythropoietin Drugs Market?

The Global Erythropoietin Drugs Market is estimated to be worth $11369.8 Million by 2027.

Who are the key companies in the Global Erythropoietin Drugs Market?

Key companies in the Global Erythropoietin Drugs Market include Amgen Inc., Biocon Limited, Celltrion, Inc., Hospira Inc., Intas Pharmaceuticals, Johnson & Johnson, LG Life Sciences Ltd., Ranbaxy Laboratories Ltd. and Teva Pharmaceutical Industries Ltd..

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidence of HIV, cancer, and ESRD globally
5.1.1.2. Increasing development of synthetic forms of ESRD with enhanced recombinant DNA technology
5.1.2. Restraints
5.1.2.1. High cost EPO drugs
5.1.3. Opportunities
5.1.3.1. Introduction of novel drugs and cost-efficient biosimilar formulations
5.1.3.2. Ongoing robust research and development activities to develop innovative molecules
5.1.4. Challenges
5.1.4.1. Stringent regulatory protocols for drug approval
5.2. Cumulative Impact of COVID-19
6. Erythropoietin Drugs Market, by Drug Class
6.1. Introduction
6.2. Biologics
6.3. Biosimilars
7. Erythropoietin Drugs Market, by Product
7.1. Introduction
7.2. Darbepoetin-alfa
7.3. Epoetin-alfa
7.4. Epoetin-beta
8. Erythropoietin Drugs Market, by Application
8.1. Introduction
8.2. Cancer
8.3. Hematology
8.4. Neurology
8.5. Renal Diseases
9. Americas Erythropoietin Drugs Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Erythropoietin Drugs Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Erythropoietin Drugs Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Amgen Inc.
13.2. Biocon Limited
13.3. Celltrion, Inc.
13.4. Hospira Inc.
13.5. Intas Pharmaceuticals
13.6. Johnson & Johnson
13.7. LG Life Sciences Ltd.
13.8. Ranbaxy Laboratories Ltd.
13.9. Roche Holding AG
13.10. Teva Pharmaceutical Industries Ltd.
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL ERYTHROPOIETIN DRUGS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL ERYTHROPOIETIN DRUGS MARKET DYNAMICS
FIGURE 8. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2021 VS 2027 (%)
FIGURE 9. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2027
FIGURE 11. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY BIOLOGICS, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY BIOLOGICS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY BIOSIMILARS, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY BIOSIMILARS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 16. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2027
FIGURE 18. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY DARBEPOETIN-ALFA, 2019-2027 (USD MILLION)
FIGURE 19. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY DARBEPOETIN-ALFA, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 20. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY EPOETIN-ALFA, 2019-2027 (USD MILLION)
FIGURE 21. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY EPOETIN-ALFA, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 22. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY EPOETIN-BETA, 2019-2027 (USD MILLION)
FIGURE 23. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY EPOETIN-BETA, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 24. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 25. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2027
FIGURE 27. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY CANCER, 2019-2027 (USD MILLION)
FIGURE 28. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY CANCER, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 29. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY HEMATOLOGY, 2019-2027 (USD MILLION)
FIGURE 30. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 31. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY NEUROLOGY, 2019-2027 (USD MILLION)
FIGURE 32. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY NEUROLOGY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 33. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY RENAL DISEASES, 2019-2027 (USD MILLION)
FIGURE 34. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY RENAL DISEASES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 35. AMERICAS ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 36. AMERICAS ERYTHROPOIETIN DRUGS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 37. AMERICAS ERYTHROPOIETIN DRUGS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 38. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ERYTHROPOIETIN DRUGS MARKET SIZE, BY COUNTRY, 2027
FIGURE 39. ARGENTINA ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 40. BRAZIL ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 41. CANADA ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 42. MEXICO ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 43. UNITED STATES ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 44. UNITED STATES ERYTHROPOIETIN DRUGS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 45. UNITED STATES ERYTHROPOIETIN DRUGS MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 46. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ERYTHROPOIETIN DRUGS MARKET SIZE, BY STATE, 2027
FIGURE 47. ASIA-PACIFIC ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 48. ASIA-PACIFIC ERYTHROPOIETIN DRUGS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 49. ASIA-PACIFIC ERYTHROPOIETIN DRUGS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 50. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ERYTHROPOIETIN DRUGS MARKET SIZE, BY COUNTRY, 2027
FIGURE 51. AUSTRALIA ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 52. CHINA ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 53. INDIA ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 54. INDONESIA ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 55. JAPAN ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 56. MALAYSIA ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 57. PHILIPPINES ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 58. SINGAPORE ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 59. SOUTH KOREA ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 60. TAIWAN ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 61. THAILAND ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 62. EUROPE, MIDDLE EAST & AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. EUROPE, MIDDLE EAST & AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 64. EUROPE, MIDDLE EAST & AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 65. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, BY COUNTRY, 2027
FIGURE 66. FRANCE ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 67. GERMANY ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 68. ITALY ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 69. NETHERLANDS ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 70. QATAR ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 71. RUSSIA ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 72. SAUDI ARABIA ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 73. SOUTH AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 74. SPAIN ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 75. UNITED ARAB EMIRATES ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 76. UNITED KINGDOM ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 77. GLOBAL ERYTHROPOIETIN DRUGS MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 78. GLOBAL ERYTHROPOIETIN DRUGS MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 79. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ERYTHROPOIETIN DRUGS MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL ERYTHROPOIETIN DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 6. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY BIOLOGICS, BY REGION, 2019-2027 (USD MILLION)
TABLE 7. AMERICAS ERYTHROPOIETIN DRUGS MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES ERYTHROPOIETIN DRUGS MARKET SIZE, BY BIOLOGICS, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. ASIA-PACIFIC ERYTHROPOIETIN DRUGS MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY BIOSIMILARS, BY REGION, 2019-2027 (USD MILLION)
TABLE 12. AMERICAS ERYTHROPOIETIN DRUGS MARKET SIZE, BY BIOSIMILARS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES ERYTHROPOIETIN DRUGS MARKET SIZE, BY BIOSIMILARS, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. ASIA-PACIFIC ERYTHROPOIETIN DRUGS MARKET SIZE, BY BIOSIMILARS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, BY BIOSIMILARS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 17. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY DARBEPOETIN-ALFA, BY REGION, 2019-2027 (USD MILLION)
TABLE 18. AMERICAS ERYTHROPOIETIN DRUGS MARKET SIZE, BY DARBEPOETIN-ALFA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 19. UNITED STATES ERYTHROPOIETIN DRUGS MARKET SIZE, BY DARBEPOETIN-ALFA, BY STATE, 2019-2027 (USD MILLION)
TABLE 20. ASIA-PACIFIC ERYTHROPOIETIN DRUGS MARKET SIZE, BY DARBEPOETIN-ALFA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. EUROPE, MIDDLE EAST & AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, BY DARBEPOETIN-ALFA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 22. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY EPOETIN-ALFA, BY REGION, 2019-2027 (USD MILLION)
TABLE 23. AMERICAS ERYTHROPOIETIN DRUGS MARKET SIZE, BY EPOETIN-ALFA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. UNITED STATES ERYTHROPOIETIN DRUGS MARKET SIZE, BY EPOETIN-ALFA, BY STATE, 2019-2027 (USD MILLION)
TABLE 25. ASIA-PACIFIC ERYTHROPOIETIN DRUGS MARKET SIZE, BY EPOETIN-ALFA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. EUROPE, MIDDLE EAST & AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, BY EPOETIN-ALFA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 27. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY EPOETIN-BETA, BY REGION, 2019-2027 (USD MILLION)
TABLE 28. AMERICAS ERYTHROPOIETIN DRUGS MARKET SIZE, BY EPOETIN-BETA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 29. UNITED STATES ERYTHROPOIETIN DRUGS MARKET SIZE, BY EPOETIN-BETA, BY STATE, 2019-2027 (USD MILLION)
TABLE 30. ASIA-PACIFIC ERYTHROPOIETIN DRUGS MARKET SIZE, BY EPOETIN-BETA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 31. EUROPE, MIDDLE EAST & AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, BY EPOETIN-BETA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 32. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 33. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY CANCER, BY REGION, 2019-2027 (USD MILLION)
TABLE 34. AMERICAS ERYTHROPOIETIN DRUGS MARKET SIZE, BY CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 35. UNITED STATES ERYTHROPOIETIN DRUGS MARKET SIZE, BY CANCER, BY STATE, 2019-2027 (USD MILLION)
TABLE 36. ASIA-PACIFIC ERYTHROPOIETIN DRUGS MARKET SIZE, BY CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 37. EUROPE, MIDDLE EAST & AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, BY CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 38. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2019-2027 (USD MILLION)
TABLE 39. AMERICAS ERYTHROPOIETIN DRUGS MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 40. UNITED STATES ERYTHROPOIETIN DRUGS MARKET SIZE, BY HEMATOLOGY, BY STATE, 2019-2027 (USD MILLION)
TABLE 41. ASIA-PACIFIC ERYTHROPOIETIN DRUGS MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 42. EUROPE, MIDDLE EAST & AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 43. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY NEUROLOGY, BY REGION, 2019-2027 (USD MILLION)
TABLE 44. AMERICAS ERYTHROPOIETIN DRUGS MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 45. UNITED STATES ERYTHROPOIETIN DRUGS MARKET SIZE, BY NEUROLOGY, BY STATE, 2019-2027 (USD MILLION)
TABLE 46. ASIA-PACIFIC ERYTHROPOIETIN DRUGS MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 47. EUROPE, MIDDLE EAST & AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 48. GLOBAL ERYTHROPOIETIN DRUGS MARKET SIZE, BY RENAL DISEASES, BY REGION, 2019-2027 (USD MILLION)
TABLE 49. AMERICAS ERYTHROPOIETIN DRUGS MARKET SIZE, BY RENAL DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 50. UNITED STATES ERYTHROPOIETIN DRUGS MARKET SIZE, BY RENAL DISEASES, BY STATE, 2019-2027 (USD MILLION)
TABLE 51. ASIA-PACIFIC ERYTHROPOIETIN DRUGS MARKET SIZE, BY RENAL DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 52. EUROPE, MIDDLE EAST & AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, BY RENAL DISEASES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 53. AMERICAS ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 54. AMERICAS ERYTHROPOIETIN DRUGS MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 55. AMERICAS ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 56. AMERICAS ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 57. AMERICAS ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 58. ARGENTINA ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 59. ARGENTINA ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 60. ARGENTINA ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 61. ARGENTINA ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 62. BRAZIL ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 63. BRAZIL ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 64. BRAZIL ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 65. BRAZIL ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 66. CANADA ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 67. CANADA ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 68. CANADA ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 69. CANADA ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 70. MEXICO ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 71. MEXICO ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 72. MEXICO ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 73. MEXICO ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 74. UNITED STATES ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 75. UNITED STATES ERYTHROPOIETIN DRUGS MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 76. UNITED STATES ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 77. UNITED STATES ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 78. UNITED STATES ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 79. ASIA-PACIFIC ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 80. ASIA-PACIFIC ERYTHROPOIETIN DRUGS MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 81. ASIA-PACIFIC ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 82. ASIA-PACIFIC ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 83. ASIA-PACIFIC ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 84. AUSTRALIA ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 85. AUSTRALIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 86. AUSTRALIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 87. AUSTRALIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 88. CHINA ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 89. CHINA ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 90. CHINA ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 91. CHINA ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 92. INDIA ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 93. INDIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 94. INDIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 95. INDIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 96. INDONESIA ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 97. INDONESIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 98. INDONESIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 99. INDONESIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 100. JAPAN ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 101. JAPAN ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 102. JAPAN ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 103. JAPAN ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 104. MALAYSIA ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 105. MALAYSIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 106. MALAYSIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 107. MALAYSIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 108. PHILIPPINES ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 109. PHILIPPINES ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 110. PHILIPPINES ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 111. PHILIPPINES ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 112. SINGAPORE ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 113. SINGAPORE ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 114. SINGAPORE ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 115. SINGAPORE ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 116. SOUTH KOREA ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 117. SOUTH KOREA ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 118. SOUTH KOREA ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 119. SOUTH KOREA ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 120. TAIWAN ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 121. TAIWAN ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 122. TAIWAN ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 123. TAIWAN ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 124. THAILAND ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 125. THAILAND ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 126. THAILAND ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 127. THAILAND ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 133. FRANCE ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 134. FRANCE ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 135. FRANCE ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 136. FRANCE ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 137. GERMANY ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 138. GERMANY ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 139. GERMANY ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 140. GERMANY ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 141. ITALY ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 142. ITALY ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 143. ITALY ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 144. ITALY ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 145. NETHERLANDS ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 146. NETHERLANDS ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 147. NETHERLANDS ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 148. NETHERLANDS ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 149. QATAR ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 150. QATAR ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 151. QATAR ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 152. QATAR ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 153. RUSSIA ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 154. RUSSIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 155. RUSSIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 156. RUSSIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 157. SAUDI ARABIA ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 158. SAUDI ARABIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 159. SAUDI ARABIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 160. SAUDI ARABIA ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 161. SOUTH AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 162. SOUTH AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 163. SOUTH AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 164. SOUTH AFRICA ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 165. SPAIN ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 166. SPAIN ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 167. SPAIN ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 168. SPAIN ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 169. UNITED ARAB EMIRATES ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 170. UNITED ARAB EMIRATES ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 171. UNITED ARAB EMIRATES ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 172. UNITED ARAB EMIRATES ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 173. UNITED KINGDOM ERYTHROPOIETIN DRUGS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 174. UNITED KINGDOM ERYTHROPOIETIN DRUGS MARKET SIZE, BY DRUG CLASS, 2019-2027 (USD MILLION)
TABLE 175. UNITED KINGDOM ERYTHROPOIETIN DRUGS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 176. UNITED KINGDOM ERYTHROPOIETIN DRUGS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 177. GLOBAL ERYTHROPOIETIN DRUGS MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 178. GLOBAL ERYTHROPOIETIN DRUGS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 179. GLOBAL ERYTHROPOIETIN DRUGS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 180. GLOBAL ERYTHROPOIETIN DRUGS MARKET RANKING
TABLE 181. GLOBAL ERYTHROPOIETIN DRUGS MARKET SHARE, BY KEY PLAYER, 2021
TABLE 182. GLOBAL ERYTHROPOIETIN DRUGS MARKET MERGER & ACQUISITION
TABLE 183. GLOBAL ERYTHROPOIETIN DRUGS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 184. GLOBAL ERYTHROPOIETIN DRUGS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 185. GLOBAL ERYTHROPOIETIN DRUGS MARKET INVESTMENT & FUNDING
TABLE 186. GLOBAL ERYTHROPOIETIN DRUGS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 187. GLOBAL ERYTHROPOIETIN DRUGS MARKET: LICENSE & PRICING

Companies Mentioned

  • Amgen Inc.
  • Biocon Limited
  • Celltrion, Inc.
  • Hospira Inc.
  • Intas Pharmaceuticals
  • Johnson & Johnson
  • LG Life Sciences Ltd.
  • Ranbaxy Laboratories Ltd.
  • Roche Holding AG
  • Teva Pharmaceutical Industries Ltd.

Methodology

Loading
LOADING...